Overview

Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical Study

Status:
Unknown status

Trial end date:
2019-03-01

Target enrollment:

Participant gender:

Summary

This study mainly evaluate the clinical effect of Apatinib in the treatment of patients with pulmonary metastasis of hepatocellular carcinoma.Half of participants will receive Apatinib and transcatheter arterial chemoembolization (TACE) therapy in combination,while the other half will receive TACE therapy alone.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Zhejiang Cancer Hospital

Collaborators:

First Affiliated Hospital of Wenzhou Medical University
First Affiliated Hospital of Zhejiang University
Ningbo No.2 Hospital
Second Affiliated Hospital, School of Medicine, Zhejiang University
The Central Hospital of Lishui City

Treatments:

Apatinib
Chlorotrianisene